🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

549 results for “Hong” Clear

  1. Simethicone

    Hospital Authority, Hong Kong

    Colonoscopy

    approved small molecule completed

    1 trial

  2. Simvastatin

    Hospital Authority, Hong Kong

    Obesity

    approved small molecule active

    1 trial

  3. Sodium valproate

    Chinese University of Hong Kong

    Epilepsy

    approved small molecule active

    1 trial

  4. Tocilizumab

    Shanghai Zhongshan Hospital

    Takayasu Arteritis

    approved mab active

    1 trial

  5. Topical Anesthetic

    Hospital Authority, Hong Kong

    Radial Artery Spasm

    approved small molecule active

    1 trial

  6. Transepicardial with Transseptal CD 133+ Implantation

    Hospital Authority, Hong Kong

    Coronary Artery Disease

    approved mab completed

    1 trial

  7. Trimebutine 100 MG

    Hospital Authority, Hong Kong

    Helicobacter Pylori Infection

    approved small molecule completed

    1 trial

  8. Trivalent live attenuated seasonal influenza vaccine

    The University of Hong Kong

    Influenza Virus Infection

    approved mab completed

    1 trial

  9. Valproic acid

    Hospital Authority, Hong Kong

    Drug Resistant Epilepsy

    approved small molecule active

    1 trial

  10. Vemlidy

    Hospital Authority, Hong Kong

    Chronic Hepatitis b

    approved small molecule active

    1 trial

  11. Vitamin D3

    Hospital Authority, Hong Kong

    Bronchiectasis

    approved small molecule active

    1 trial

  12. Z-Brace interbody fusion device

    Hospital Authority, Hong Kong

    Cervical Disc Degeneration

    approved other active

    1 trial

  13. conbercept

    Hospital Authority, Hong Kong

    Polypoidal Choroidal Vasculopathy

    approved small molecule completed

    1 trial

  14. conventional dose epinephrine

    Hospital Authority, Hong Kong

    Croup

    approved small molecule active

    1 trial

  15. film dressing by adhesive

    Chinese University of Hong Kong

    Chronic Peritoneal Dialysis

    approved other terminated

    1 trial

  16. fluticasone/salmeterol, tiotropium

    Hospital Authority, Hong Kong

    COPD

    approved small molecule active

    1 trial

  17. gastric scintigraphy

    Hospital Authority, Hong Kong

    Functional Dyspepsia

    approved other terminated

    1 trial

  18. glargine + exenatide

    Hong Kong Baptist University

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  19. inactivated EV71 vaccine (KMB-17 cells)

    Chinese University of Hong Kong

    Hand, Foot and Mouth Disease (HFMD)

    approved mab completed

    1 trial

  20. isoniazid, rifampin, pyrazinamide

    Hospital Authority, Hong Kong

    Hepatitis

    approved small molecule active

    1 trial

  21. lactate group:lactate acide clearance directed group; ScvO2 group:ScvO2 directed group;control group

    Chinese University of Hong Kong

    Shock, Septic

    approved other completed

    1 trial

  22. mirabegron

    Hospital Authority, Hong Kong

    Sjogren's Syndrome

    approved small molecule active

    1 trial

  23. moxifloxacin

    Hospital Authority, Hong Kong

    Intra-abdominal Infection

    approved small molecule completed

    1 trial

  24. omeprazole plus amoxicillin

    Hospital Authority, Hong Kong

    Duodenal Ulcer

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources